Status:
COMPLETED
Universal Genetic Testing Versus Guidelines-Directed Testing for Germline Pathogenic Variants Among Non-Western Patients With Breast Cancer
Lead Sponsor:
King Hussein Cancer Center
Conditions:
Breast Cancer
Eligibility:
All Genders
18+ years
Brief Summary
The study aims to examinethe pattern and frequency of pathogenic variants among all newly diagnosed breast cancer patients in a genetically distinct population. Additionally, the uptake rate of "casca...
Eligibility Criteria
Inclusion
- Adult patient, age ≥ 18 years at time of cancer diagnosis
- Pathology proven diagnosis of breast cancer (including DCIS); any stage. (prior history of cancer is allowed)
- Willingness to participate
- Signed consent form.
Exclusion
- \- Major psychiatric disorder (defined as: patients followed by a psychiatrist and on antipsychotic medications
Key Trial Info
Start Date :
April 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 1 2025
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT04920656
Start Date
April 1 2021
End Date
February 1 2025
Last Update
March 19 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
King Hussein Cancer Center
Amman, Amman Governorate, Jordan, 11941